INTERFERON-ALPHA-2 (IFN) PLUS HYDROXYUREA FOR TREATMENT OF JUVENILE CHRONIC MYELOGENOUS LEUKEMIA

被引：4
|
作者：
SUTTORP, M
RISTER, M
SCHMITZ, N
机构：
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT PEDIAT,W-2300 KIEL 1,GERMANY
[2] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT INTERNAL MED 2,BONE MARROW TRANSPLANT UNIT,W-2300 KIEL 1,GERMANY
[3] KRANKENHAUS KEMPERHOF,DEPT PEDIAT,W-5400 KOBLENZ,GERMANY
[4] CHRISTIAN ALBRECHTS UNIV KIEL,CHILDRENS HOSP,CHWANENWEG 20,D-24105 KIEL,GERMANY
来源：
MEDICAL AND PEDIATRIC ONCOLOGY | 1994年 / 22卷 / 05期
关键词：
D O I：
10.1002/mpo.2950220513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：358 / 359
页数：2
相关论文
共 50 条
  • [1] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH RECOMBINANT INTERFERON-ALPHA-2
    DIEDRICH, H
    VONWUSSOW, P
    FREUND, M
    LEBLANC, S
    LINK, H
    WILKE, HJ
    POLIWODA, H
    BLUT, 1986, 53 (03): : 236 - 236
  • [2] CONGENITAL JUVENILE CHRONIC MYELOGENOUS LEUKEMIA - THERAPEUTIC TRIAL WITH INTERFERON-ALPHA-2
    HAZANI, A
    BARAK, Y
    BERANT, M
    BARMAOR, A
    MEDICAL AND PEDIATRIC ONCOLOGY, 1993, 21 (01): : 73 - 76
  • [3] CHRONIC MYELOID-LEUKEMIA TREATMENT WITH RECOMBINANT INTERFERON-ALPHA-2
    STROZHA, I
    PETUKHOV, V
    BONDARE, D
    FELDMANE, G
    DUKS, A
    TEILANE, I
    MEDNE, I
    MAURITSAS, M
    GRINBERGA, L
    TERAPEVTICHESKII ARKHIV, 1993, 65 (10) : 62 - 66
  • [4] HEMATOLOGICAL AND GENETIC FINDINGS IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH RECOMBINANT INTERFERON-ALPHA-2
    GASTL, G
    LEITER, E
    AULITZKY, W
    TILG, H
    VONLUTTICHAU, I
    RAPP, U
    HUBER, C
    BLUT, 1986, 53 (03): : 236 - 236
  • [5] RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA
    HEHLMANN, R
    HEIMPEL, H
    HASFORD, J
    KOLB, HJ
    PRALLE, H
    HOSSFELD, DK
    QUEISSER, W
    LOFFLER, H
    HOCHHAUS, A
    HEINZE, B
    GEORGII, A
    BARTRAM, CR
    GRIESSHAMMER, M
    BERGMANN, L
    ESSERS, U
    FALGE, C
    QUEISSER, U
    MEYER, P
    SCHMITZ, N
    EIMERMACHER, H
    WALTHER, F
    FETT, W
    KLEEBERG, UR
    KABISCH, A
    NERL, C
    ZIMMERMANN, R
    MEURET, G
    TICHELLI, A
    KANZ, L
    TIGGES, FJ
    SCHMID, L
    BROCKHAUS, W
    TOBLER, A
    REITER, A
    PERKER, M
    EMMERICH, B
    VERPOORT, K
    ZANKOVICH, R
    VONWUSSOW, P
    PRUMMER, O
    THIELE, J
    BUHR, T
    CARBONELL, F
    ANSARI, H
    BLOOD, 1994, 84 (12) : 4064 - 4077
  • [6] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA
    GUILHOT, F
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1991, 33 (02): : 200 - 201
  • [7] Treatment of refractory leukemia with hydroxyurea (HU) plus alpha 2a interferon (IFN). Impact on tumoral mass.
    OvillaMartinez, R
    RubioBorja, ME
    Sosa, R
    Majluf, A
    BLOOD, 1997, 90 (10) : 4007 - 4007
  • [8] INTERFERON-ALPHA FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
    THALER, J
    ACTA MEDICA AUSTRIACA, 1993, 20 (03) : 65 - 69
  • [9] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA BY ALPHA-INTERFERON
    GUILHOT, F
    M S-MEDECINE SCIENCES, 1991, 7 (05): : 453 - 459
  • [10] Treatment of patients with multiply myeloma (MM) and chronic myelogenous leukemia (CML) with alpha-2 interferon (IFN).
    Bessmeltsev, SS
    Rukavitsyn, OA
    Abdulkadyrov, KM
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 711 - 711
12345